Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mathai Mammen


  • Director at 10X Genomics Inc. (TXG), 2019-09-16
  • Svp, Research & Development at Theravance Biopharma Inc. (TBPH), 2016-03-17
  • Svp, Research & Early Clin Dev at Theravance Inc (THRX), 2014-08-22
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
THRX $40.04 4,600 Officer 186,623 2014-02-14 Filing
THRX $39.26 30,400 Officer 191,223 2014-02-14 Filing
THRX $36.51 7,000 Officer 211,705 2013-07-30 Filing
THRX $34.34 200 Officer 205,976 2013-04-30 Filing
THRX $33.72 6,800 Officer 206,176 2013-04-30 Filing